Meribank Biotech , Ltd Goodwill

The latest goodwill for 4724.TWO is $280M as of June 2026. That compares with $280M in the prior-year period — down 0.7% year over year. Investors often review this figure alongside Meribank Biotech , Ltd's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4724.TWO's goodwill moved from $280M to $280M — a 0.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Meribank Biotech , Ltd's operating scale or balance-sheet position.

A goodwill figure of $280M for 4724.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 4724.TWO's goodwill ($280M), review year-over-year change from $280M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Meribank Biotech , Ltd's goodwill against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.